Inke exhibited at CPhI Worldwide in Frankfurt in October 2017
For the first time, NuPharm was present as a Group at world’s leading pharmaceutical networking event, CPhI Worldwide, which was held at Frankfurt Messe in October 2017.
The NuPharm Group, created in 2016, is a strategic combination of leading European pharmaceutical companies with extensive experience, currently comprising Inke, Laboratorios Lesvi, neuraxpharm, Qualigen and FB Health.
Many thanks to all NuPharm’s partners, customers and friends who visited us there and helped to make the event a success.
During 2023, Inke has increased its production capacity by making a significant investment in new reactors and clean rooms. This initiative has been carried out with the support of ACCIÓ from the Generalitat de Catalunya.
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs